A human tumor-immune organoid model of glioblastoma

A major obstacle to identifying effective therapies for the aggressive brain tumor glioblastoma is the lack of human-specific, immunocompetent models that reflect the human tumor microenvironment. To address this, we developed the immune-human organoid tumor transplantation (iHOTT) model, an autologous co-culture platform that integrates patient-derived tumor cells and matched peripheral blood mononuclear cells within human cortical organoids to enable the study of patient-specific immune responses and tumor-immune interactions. This platform preserves tumor and immune populations, immune signaling, and cell-cell interactions observed in patient tumors. Treatment of iHOTT with pembrolizumab, a checkpoint inhibitor, mirrors cell-type shifts and cell-cell interactions observed in patients. T cell receptor (TCR) sequencing further reveals pembrolizumab-driven expansion of stem-like CD4 T cell clonotypes exhibiting patient-specific repertoires. These findings establish iHOTT as a physiologically relevant platform for exploring autologous tumor-immune interactions and underscore the need for antigen-targeted strategies to enhance immunotherapy in glioblastoma.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2026-01-01
DOI
https://doi.org/10.1016/j.celrep.2025.116790
Citations
2
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
73.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A human tumor-immune organoid model of glioblastoma

David A. Nathanson, Richard G. Everson, Gilbert Herrera, Matthew Li et al.
2 citations
Cell Reports
Glioma Diagnosis and Treatment
73.86
article

A human tumor-immune organoid model of glioblastoma

David A. Nathanson, Richard G. Everson, Gilbert Herrera, Matthew Li, Antoni Martija, Ryan L. Kan, Elisa Fazzari, Aparna Bhaduri, A. Hongjun Wang, Linda M. Liau, Daria Azizad, Amber Monteleone, Kunal S. Patel, Trinh Phan, Robert M. Prins, Lu Sun, Shivani Baisiwala, Won Kim
article en
2 citations

Abstract

A major obstacle to identifying effective therapies for the aggressive brain tumor glioblastoma is the lack of human-specific, immunocompetent models that reflect the human tumor microenvironment. To address this, we developed the immune-human organoid tumor transplantation (iHOTT) model, an autologous co-culture platform that integrates patient-derived tumor cells and matched peripheral blood mononuclear cells within human cortical organoids to enable the study of patient-specific immune responses and tumor-immune interactions. This platform preserves tumor and immune populations, immune signaling, and cell-cell interactions observed in patient tumors. Treatment of iHOTT with pembrolizumab, a checkpoint inhibitor, mirrors cell-type shifts and cell-cell interactions observed in patients. T cell receptor (TCR) sequencing further reveals pembrolizumab-driven expansion of stem-like CD4 T cell clonotypes exhibiting patient-specific repertoires. These findings establish iHOTT as a physiologically relevant platform for exploring autologous tumor-immune interactions and underscore the need for antigen-targeted strategies to enhance immunotherapy in glioblastoma.

Cell ReportsVol. 45(1)
University of California, Los Angeles (US), UCLA Health (US)
Alexander and Margaret Stewart Trust, McKnight Foundation, Sontag Foundation, California Institute of Technology, Rose Hills Foundation, Swim Across America, National Institutes of Health, National Cancer Institute, Jonsson Comprehensive Cancer Center, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles
Good health and well-being
Openalex Percentile: Top 0%
Glioma Diagnosis and Treatment
73.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.